Biomarkers of NAFLD progression: a lipidomics approach to an epidemic(1)

The spectrum of nonalcoholic fatty liver disease (NAFLD) includes steatosis, nonalcoholic steatohepatitis (NASH), and cirrhosis. Recognition and timely diagnosis of these different stages, particularly NASH, is important for both potential reversibility and limitation of complications. Liver biopsy...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Lipid Res
المؤلفون الرئيسيون: Gorden, D. Lee, Myers, David S., Ivanova, Pavlina T., Fahy, Eoin, Maurya, Mano R., Gupta, Shakti, Min, Jun, Spann, Nathanael J., McDonald, Jeffrey G., Kelly, Samuel L., Duan, Jingjing, Sullards, M. Cameron, Leiker, Thomas J., Barkley, Robert M., Quehenberger, Oswald, Armando, Aaron M., Milne, Stephen B., Mathews, Thomas P., Armstrong, Michelle D., Li, Chijun, Melvin, Willie V., Clements, Ronald H., Washington, M. Kay, Mendonsa, Alisha M., Witztum, Joseph L., Guan, Ziqiang, Glass, Christopher K., Murphy, Robert C., Dennis, Edward A., Merrill, Alfred H., Russell, David W., Subramaniam, Shankar, Brown, H. Alex
التنسيق: Artigo
اللغة:Inglês
منشور في: The American Society for Biochemistry and Molecular Biology 2015
الموضوعات:
Patient-Oriented and Epidemiological Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4340319/
https://ncbi.nlm.nih.gov/pubmed/25598080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P056002
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة